Webinar – Discussion On Our Next Article Pick + $CALA $AFMD $GLYC And More!
Author: Scott Matusow
Commentary – Explaining Real Economics + IoT + QE + CB’S and A lot More Edu Stuff
Commentary – Explaining Real Economics + QE + CB’S and A lot More Edu Stuff
Analyst Report on Our Next Featured Biotech – Article Soon!
Analyst Report on Our Next Featured Biotech – Article Soon!
Audio – $GLYC $CALA and $XLNX Explained + Market Outlook
Audio – $GLYC $CALA and $XLNX Explained + Market Outlook
Audio – Further $XLNX Explanation + Updates On Our Plays
In this audio, I give our opinion on the recent $XLNX note offering and why we think it bolsters our acquisition view. I go over what has transpired there over the last year and give our updated thesis on that.…
Morgan Stanley $XLNX analyst report after recent analyst meeting + Scott’s Commentary
Morgan Stanley $XLNX analyst report after recent analyst meeting. I highlight in bold-black the key points and add commentary and why the market has $XLNX grossly undervalued, and why management is DELIBERATELY Sandbagging in my strong opinion. Semiconductors / United…
Market Commentary – Explaining $CALA Potential + $GLYC and More!
Market Commentary – Explaining $CALA Potential + $GLYC and More!
Webinar – Discussing $GLYC + Biotech + Explaining How We Read Filings And Do DD
In this audio webinar, Danny and I dig deep into $GLYC and explain the relevance of what the company has recently accomplished, and why our bullishness here remains and is even growing. In between out GLYC talk, we discuss how…
Our New Clinical Stage Biotech Play: Glycomimetics
Article on Our New Clinical Stage Biotech Play
Audio Webinar – Understanding Pump & Dump & Fomenting
Audio Webinar – Understanding Pump & Dump & Fomenting
